Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

Elisabeth I. Heath, Barbara A. Burtness, Lawrence Kleinberg, Ronald R. Salem, Stephen C. Yang, Richard F. Heitmiller, Marcia I. Canto, Jonathan P.S. Knisely, Mark Topazian, Elizabeth Montgomery, Nancy Tsottles, Yazdi Pithavala, Bridget Rohmiller, Mary Collier, Arlene A. Forastiere

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences